MedPath

Indirubin

Generic Name
Indirubin
Drug Type
Small Molecule
Chemical Formula
C16H10N2O2
CAS Number
479-41-4
Unique Ingredient Identifier
1LXW6D3W2Z

Overview

Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).

Background

Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).

Indication

主要用于治疗慢性粒细胞白血病的慢性期患者,有少量报道初步认为本品对缩小伴有巨脾的骨髓纤维化患者脾脏亦可能有一定疗效。

Associated Conditions

No associated conditions information available.

Clinical Trials

Not Applicable
Completed
Posted: 2012/11/28
Sponsor:
Chang Gung Memorial ...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath